Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Change in Inventory (2021 - 2025)

HeartSciences (HSCS) has disclosed Change in Inventory for 5 consecutive years, with $7778.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 21.18% year-over-year to $7778.0, compared with a TTM value of $4378.0 through Oct 2025, up 119.96%, and an annual FY2025 reading of $21088.0, up 144.7% over the prior year.
  • Change in Inventory was $7778.0 for Q4 2025 at HeartSciences, up from -$760.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $13860.0 in Q3 2024 and bottomed at -$41099.0 in Q2 2024.
  • Average Change in Inventory over 5 years is -$6131.3, with a median of -$760.0 recorded in 2023.
  • The sharpest move saw Change in Inventory surged 110.49% in 2022, then tumbled 7372.55% in 2024.
  • Year by year, Change in Inventory stood at -$23397.0 in 2021, then skyrocketed by 115.09% to $3530.0 in 2022, then tumbled by 115.58% to -$550.0 in 2023, then skyrocketed by 1894.18% to $9868.0 in 2024, then decreased by 21.18% to $7778.0 in 2025.
  • Business Quant data shows Change in Inventory for HSCS at $7778.0 in Q4 2025, -$760.0 in Q3 2025, and -$1880.0 in Q2 2025.